Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025)

Ani Pharmaceuticals (ANIP) reported Preferred Dividend Payments of $344000.0 for Q3 2025, down 15.27% on a YoY basis from $406000.0 in Q3 2024, and down 15.48% sequentially from $407000.0 in Q2 2025.

Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025) Analysis & Trends

Ani Pharmaceuticals (ANIP) has 7 years of Preferred Dividend Payments data on file, last reported at $344000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Preferred Dividend Payments fell 15.27% year-over-year to $344000.0; the trailing twelve-month figure through Mar 2026 stood at $751000.0 (down 53.78% YoY), and the FY2025 full-year result was $1.2 million, down 28.8% from the prior year.
  • Preferred Dividend Payments slipped to $344000.0 in Q3 2025, from $407000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $407000.0 in Q2 2022 to a low of $190000.0 in Q4 2021.
  • A 5-year average of $388875.0 and a median of $406000.0 in 2022 frame the typical range for Preferred Dividend Payments.
  • Across the five-year window, Preferred Dividend Payments surged 114.21% in 2022 and decreased 15.27% in 2025, its largest moves.
  • Tracing ANIP's Preferred Dividend Payments over 5 years: stood at $190000.0 in 2021, then soared by 114.21% to $407000.0 in 2022, then retreated by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then fell by 15.27% to $344000.0 in 2025.
  • Business Quant data shows ANIP's Preferred Dividend Payments at $344000.0 in Q3 2025, $407000.0 in Q2 2025, and $406000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Ani Pharmaceuticals 1.64 Bn 1.33 Bn 143.88 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 344,000.00
Jun 30, 2025 407,000.00
Mar 31, 2025 406,000.00
Dec 31, 2024 406,000.00
Sep 30, 2024 406,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 406,000.00
Dec 31, 2023 406,000.00
Sep 30, 2023 406,000.00
Jun 30, 2023 407,000.00
Mar 31, 2023 406,000.00
Dec 31, 2022 407,000.00
Sep 30, 2022 406,000.00
Jun 30, 2022 407,000.00
Mar 31, 2022 405,000.00
Dec 31, 2021 190,000.00
Dec 31, 2013 1,000.00
Jun 30, 2013 2.37 Mn
Mar 31, 2013 2.60 Mn
Dec 31, 2012 2.60 Mn